Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Antisense therapy for CMV retinitis receives priority review status from FDA

June 29, 1998

Roche reviews HIV product pipeline in time for AIDS conference

June 29, 1998

Phase II trial with HGP-30W HIV vaccine begins in The Netherlands

June 29, 1998

Ziagen submitted for approval in U.S. and Europe

June 26, 1998

Compounds for the treatment of HIV infection developed at Janssen

June 26, 1998

Progenics and Pharmacopeia to jointly discover small-molecule HIV drugs

June 26, 1998

Interim results from dose-escalating phase I/II trials of PRO-542 presented at Bio '98

June 25, 1998

Searle conducts AIDS research, identifies protease inhibitors

June 25, 1998

Cel-Sci's AIDS vaccine trial expanded to include The Netherlands

June 23, 1998

Boston Biomedica receives NIH grant for AIDS vaccine research

June 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...